Analystreport

Blueprint Medicines Corp (NASDAQ: BPMC) is now covered by analysts at Barclays PLC. They set a "hold" rating and a $59.00 price target on the stock.

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com